Life-Course Trajectories of Body Mass Index, Insulin Resistance, and Incident Diabetes in Chinese Adults

Zhiyuan Ning Jinglan Zhang Bingbing Fan Yanlin Qu Chang Su Tao Zhang

Zhiyuan Ning, Jinglan Zhang, Bingbing Fan, Yanlin Qu, Chang Su, Tao Zhang. Life-Course Trajectories of Body Mass Index, Insulin Resistance, and Incident Diabetes in Chinese Adults[J]. Biomedical and Environmental Sciences. doi: 10.3967/bes2025.072
Citation: Zhiyuan Ning, Jinglan Zhang, Bingbing Fan, Yanlin Qu, Chang Su, Tao Zhang. Life-Course Trajectories of Body Mass Index, Insulin Resistance, and Incident Diabetes in Chinese Adults[J]. Biomedical and Environmental Sciences. doi: 10.3967/bes2025.072

doi: 10.3967/bes2025.072

Life-Course Trajectories of Body Mass Index, Insulin Resistance, and Incident Diabetes in Chinese Adults

More Information
    Author Bio:

    Zhiyuan Ning and

    Jinglan Zhang contributed equally

    Corresponding author: Chang Su, Tel: 86-22-83336606, E-mail: suchang@ninh.chinacdc.cnTao Zhang, Tel: 86-22-83336606, E-mail: taozhang@tmu.edu.cn
  • Generated the hypotheses: Yanlin Qu, Chang Su, and Tao Zhang ; Contributed to the analytic strategy and wrote the manuscript: Zhiyuan Ning, Jinglan Zhang, Bingbing Fan, and Yanlin Qu .Supervised field activities and edited the manuscript: Chang Su and Tao Zhang .
  • The authORs declare that they have no conflict of interest.
  • The study protocol was approved by the ethics committee of the National Institute for Nutrition and Health, China (CDC No. 201524). Informed consent was obtained from all participants before the investigation.
  • &These authors contributed equally to this work.
    • 关键词:
    •  / 
    •  / 
    •  / 
    •  
    Generated the hypotheses: Yanlin Qu, Chang Su, and Tao Zhang ; Contributed to the analytic strategy and wrote the manuscript: Zhiyuan Ning, Jinglan Zhang, Bingbing Fan, and Yanlin Qu .Supervised field activities and edited the manuscript: Chang Su and Tao Zhang .
    The authORs declare that they have no conflict of interest.
    The study protocol was approved by the ethics committee of the National Institute for Nutrition and Health, China (CDC No. 201524). Informed consent was obtained from all participants before the investigation.
    &These authors contributed equally to this work.
    注释:
    1) Authors' Contributions: 2) Competing Interests: 3) Ethics:
  • Figure  1.  Predicted trajectories of BMI in participants 20–50 years old.

    The trajectories are shown as solid lines, and 95% confidence intervals (CIs) are shown as shaded areas. The proportions of each trajectory are shown below the solid lines. BMI, body mass index (see detailed information on the curve parameters in Supplementary Table S3).

    Figure  2.  Incidence of diabetes in participants 20–50 years old across different combined categories of BMI and HOMA-IR.

    Normal indicates low-stable BMI and HOMA-IR less than 2.3 (the median of the subjects); IR indicates BMI low-stable but HOMA-IR > 2.3; IS-obesity indicates medium- or high-increasing BMI while HOMA-IR < 2.3; IR-obesity indicates medium or high-increasing BMI and HOMA-IR > 2.3. BMI, body mass index; HOMA-IR, homeostasis model assessment of insulin resistance; IR, insulin resistance; IS, insulin sensitivity.

    Figure  3.  Mediation effect of HOMA-IR on the BMI trajectories to later life diabetes mellitus association.

    Obesity is defined as both medium- and high-increasing BMI trajectories. * P < 0.001; BMI, body mass index; HOMA-IR, homeostasis model assessment of insulin resistance.

    Table  1.   Characteristics by incident diabetes mellitus at baseline and follow-up

    Variables Non-diabetics (n = 2,142) Diabetes (n = 194) P Value
    Baseline
    Age, ys 28.0 (5.3) 28.4 (5.0) 0.344
    Males, n (%) 965 (45.1) 115 (59.3) < 0.001
    BMI, kg/m2 21.7 (2.7) 23.2 (3.4) < 0.001
    Smoker, n (%) 455 (21.2) 49 (25.3) 0.226
    Drinker, n (%) 473 (22.1) 50 (25.8) 0.275
    Follow-up
    FPG, mmol/L 5.0 (0.59) 7.2 (2.66) < 0.001
    Insulin, μIU/mL 10.2 [7.3, 14.5] 14.6 [9.2, 22.7] < 0.001
    HOMA 2.22 [1.54, 3.26] 4.47 [2.54, 8.39] < 0.001
    Follow-up duration, ys 18.0 (5.9) 20.6 (5.5) < 0.001
      Note. Study variables are presented as mean (SD), median [interquartile range] or n (%), appropriately. BMI, body mass index; FPG, fasting plasma glucose; HOMA, homeostasis model assessment of insulin resistance.
    下载: 导出CSV

    Table  2.   Characteristics at baseline and follow-up by joint groups of obesity and insulin sensitivity

    Variables Normal IR IS-obesity IR-obesity P Value
    N 948 677 224 487
    Baseline
    Age, ys 28.3 (5.2) 27.8 (5.2) 28.0 (5.5) 27.9 (5.3) 0.255
    Males, n (%) 409 (43.1) 290 (42.8) 104 (46.4) 277 (56.9) * † < 0.001
    BMI, kg/m2 20.8 (1.9) 21.0 (2.0) 24.0 (2.9) * 24.1 (3.1) * < 0.001
    SBP, mmHg 111.5 (11.6) 111.5 (11.6) 114.2 (11.2) * 115.8 (11.9) * < 0.001
    DBP, mmHg 73.4 (8.9) 73.0 (9.1) 75.8 (8.4) * 76.1 (9.3) * < 0.001
    WC, cm 72.9 (6.9) 73.9 (7.9) 82.3 (9.2) * 83.2 (9.7) * < 0.001
    Smoker, n (%) 199 (21.0) 113 (16.7) 53 (23.7) 139 (28.5) * < 0.001
    Drinker, n (%) 200 (21.1) 114 (16.8) 64 (28.6) * 145 (29.8) * < 0.001
    Follow-up (WAVE = 2009)
    Age, ys 41.9 (5.4) 41.5 (5.6) 40.9 (5.6) * 41.3 (5.6) * 0.031
    BMI, kg/m2 21.7 (2.2) 22.3 (2.2) 26.5 (2.3) * 27.5 (2.7) * † < 0.001
    SBP, mmHg 115.6 (13.7) 117.5 (14.4) 122.2 (16.4) * 124.3 (16.1) * < 0.001
    DBP, mmHg 76.8 (9.9) 77.8 (10.2) 81.4 (10.3) * 84.3 (11.5) * † < 0.001
    WC, cm 76.9 (8.0) 78.9 (7.8) 89.1 (7.8) * 91.1 (8.2) * † < 0.001
    Smoker, n (%) 293 (30.9) 182 (26.9) 66 (29.5) 182 (37.4) * † 0.002
    Drinker, n (%) 332 (35.1) 224 (33.1) 93 (41.5) 214 (43.9) * < 0.001
    Energy, kcal/day 2,242 (649) 2,133 (629) 2,252 (614) 2,293 (765) < 0.001
    Carbohydrate, g/day 313.1 (103.1) 295.4 (102.1) 317.8 (98.0) 308.9 (107.0) 0.003
    Protein, g/day 68.2 (22.8) 66.7 (22.2) 69.3 (23.6) 71.4 (24.0) 0.007
    Fat intake, g/day 76.2 (33.6) 72.6 (32.5) 76.2 (30.9) 79.1 (34.9) 0.011
    FPG, mmol/L 4.8 (0.54) 5.4 (1.09) 4.9 (0.70) 5.8 (1.73) * † < 0.001
    Insulin, μIU/mL 7.3 [5.5, 8.7] 14.4 [11.9, 20.3] 7.9 [5.8, 9.0] * 16.1 [12.8, 22.8] * † < 0.001
    HOMA 1.55 [1.15, 1.92] 3.26 [2.71, 4.74] 1.71 [1.23, 1.96] * 3.83 [2.95, 5.85] * † < 0.001
    Incident Diabetes Mellitus, n (%) 29 (3.1) 60 (8.9) 13 (5.8) 92 (18.9) * † < 0.001
      Note. Study variables are presented as mean (SD), median [interquartile range] or n (%), appropriately. IR, insulin resistance; IS, insulin sensitivity; BMI, body mass index; DBP, diastolic blood pressure; SBP, systolic blood pressure; WC, waist circumference; FPG, fasting plasma glucose; HOMA, homeostasis model assessment of insulin resistance. * Indicated P < 0.05 adjusted for Bonferroni, compared with normal group. Indicated P < 0.05 adjusted for Bonferroni, compared with IS-obesity group.
    下载: 导出CSV

    Table  3.   Odds ratios (95% CI) of joint groups of obesity and insulin sensitivity for incident diabetes

    Model 1* Model 2** Model 3***
    Total
    Normal Reference Reference Reference
    IR 3.08 (1.97, 4.92) 3.13 (2.00, 5.00) 3.22 (2.05, 5.16)
    IS-obesity 1.95 (0.97, 3.74) 1.94 (0.96, 3.72) 2.05 (1.00, 3.97)
    IR-obesity 7.38 (4.84, 11.57) 7.05 (4.62, 11.07) 7.98 (5.19, 12.62)
    Males
    Normal Reference Reference Reference
    IR 2.96 (1.64, 5.54) 3.01 (1.66, 5.64) 3.05 (1.67, 5.74)
    IS-obesity 1.66 (0.63, 3.97) 1.68 (0.64, 4.03) 1.86 (0.69, 4.53)
    IR-obesity 6.11 (3.54, 11.05) 6.17 (3.58, 11.17) 7.32 (4.20, 13.41)
    Females
    Normal Reference Reference Reference
    IR 3.29 (1.68, 6.83) 3.30 (1.69, 6.84) 3.40 (1.73, 7.09)
    IS-obesity 2.31 (0.79, 6.08) 2.31 (0.79, 6.09) 2.25 (0.76, 6.02)
    IR-obesity 8.48 (4.42, 17.41) 8.50 (4.42, 17.44) 8.65 (4.45, 17.93)
      Note. IR, insulin resistance; IS, insulin sensitivity. * Unadjusted for any covariates. ** Adjusted for baseline age and sex (only for total). *** Adjusted for baseline age, sex (only for total), smoking, alcohol drinking, and follow-up years. Indicated P value < 0.05.
    下载: 导出CSV
  • [1] Wang YF, Xue H, Sun MX, et al. Prevention and control of obesity in China. Lancet Glob Health, 2019; 7, e1166−7. doi:  10.1016/S2214-109X(19)30276-1
    [2] Zhang JG, Wang HJ, Wang ZH, et al. Prevalence and stabilizing trends in overweight and obesity among children and adolescents in China, 2011-2015. BMC Public Health, 2018; 18, 571. doi:  10.1186/s12889-018-5483-9
    [3] Zhang YX, Wang ZX, Zhao JS, et al. Trends in overweight and obesity among rural children and adolescents from 1985 to 2014 in Shandong, China. Eur J Prev Cardiol, 2016; 23, 1314−20. doi:  10.1177/2047487316643830
    [4] Wang LM, Peng W, Zhao ZP, et al. Prevalence and treatment of diabetes in China, 2013-2018. JAMA, 2021; 326, 2498−506. doi:  10.1001/jama.2021.22208
    [5] Bhupathiraju SN, Hu FB. Epidemiology of obesity and diabetes and their cardiovascular complications. Circ Res, 2016; 118, 1723−35. doi:  10.1161/CIRCRESAHA.115.306825
    [6] Meijnikman AS, Gerdes VE, Nieuwdorp M, et al. Evaluating causality of gut microbiota in obesity and diabetes in humans. Endocr Rev, 2018; 39, 133−53. doi:  10.1210/er.2017-00192
    [7] Piché ME, Tchernof A, Després JP. Obesity phenotypes, diabetes, and cardiovascular diseases. Circ Res, 2020; 126, 1477−500. doi:  10.1161/CIRCRESAHA.120.316101
    [8] Chen K, Shen ZW, Gu WJ, et al. Prevalence of obesity and associated complications in China: a cross-sectional, real-world study in 15.8 million adults. Diabetes Obes Metab, 2023; 25, 3390−9. doi:  10.1111/dom.15238
    [9] Blüher M. Metabolically healthy obesity. Endocr Rev, 2020; 41, bnaa004. doi:  10.1210/endrev/bnaa004
    [10] Zhang T, Zhang HJ, Li SX, et al. Impact of adiposity on incident hypertension is modified by insulin resistance in adults: longitudinal observation from the Bogalusa heart study. Hypertension, 2016; 67, 56−62. doi:  10.1161/HYPERTENSIONAHA.115.06509
    [11] Genelhu VA, Celoria BMJ, Duarte SFP, et al. Not all obese subjects of multiethnic origin are at similar risk for developing hypertension and type 2 diabetes. Eur J Intern Med, 2009; 20, 289−95. doi:  10.1016/j.ejim.2008.09.009
    [12] Vukovic R, Mitrovic K, Milenkovic T, et al. Insulin-sensitive obese children display a favorable metabolic profile. Eur J Pediatr, 2013; 172, 201−6. doi:  10.1007/s00431-012-1867-5
    [13] Kuk JL, Ardern CI. Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care, 2009; 32, 2297-9.
    [14] Wei Y, Wang J, Han X, et al. Metabolically healthy obesity increased diabetes incidence in a middle-aged and elderly Chinese population. Diabetes Metab Res Rev, 2020; 36, e3202. doi:  10.1002/dmrr.3202
    [15] Bell JA, Kivimaki M, Hamer M. Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies. Obes Rev, 2014; 15, 504−15. doi:  10.1111/obr.12157
    [16] Ärnlöv J, Ingelsson E, Sundström J, et al. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation, 2010; 121, 230−6. doi:  10.1161/CIRCULATIONAHA.109.887521
    [17] Barber TM, Kyrou I, Randeva HS, et al. Mechanisms of insulin resistance at the crossroad of obesity with associated metabolic abnormalities and cognitive dysfunction. Int J Mol Sci, 2021; 22, 546. doi:  10.3390/ijms22020546
    [18] Liu DC, Zhao Y, Liu Y, et al. Adiposity and insulin resistance as mediators between age at menarche and type 2 diabetes mellitus. Menopause, 2020; 27, 579−85. doi:  10.1097/GME.0000000000001504
    [19] Tang A, Coster ACF, Tonks KT, et al. Longitudinal changes in insulin resistance in normal weight, overweight and obese individuals. J Clin Med, 2019; 8, 623. doi:  10.3390/jcm8050623
    [20] Xu C, Zhou GS, Zhao M, et al. Bidirectional temporal relationship between obesity and hyperinsulinemia: longitudinal observation from a Chinese cohort. BMJ Open Diabetes Res Care, 2021; 9, e002059. doi:  10.1136/bmjdrc-2020-002059
    [21] Buscemi C, Randazzo C, Barile AM, et al. Factors associated with body weight gain and insulin-resistance: a longitudinal study. Nutr Diabetes, 2024; 14, 21. doi:  10.1038/s41387-024-00283-5
    [22] Zhang B, Zhai FY, Du SF, et al. The China health and nutrition survey, 1989-2011. Obes Rev, 2014; 15, 2−7.
    [23] Li LM, Rao KQ, Kong LZ, et al. A description on the Chinese national nutrition and health survey in 2002. Chin J Epidemiol, 2005; 26, 478−84. (In Chinese)
    [24] Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985; 28, 412−9. doi:  10.1007/BF00280883
    [25] Proust-Lima C, Philipps V, Liquet B. Estimation of extended mixed models using latent classes and latent processes: the R package lcmm. J Stat Softw, 2015; 78, 1−56.
    [26] Fan BB, Yang YC, Dayimu A, et al. Body mass index trajectories during young adulthood and incident hypertension: a longitudinal cohort in Chinese population. J Am Heart Assoc, 2019; 8, e011937. doi:  10.1161/JAHA.119.011937
    [27] Lv JL, Fan BB, Wei MK, et al. Trajectories of early to mid-life adulthood BMI and incident diabetes: the China Health and Nutrition Survey. BMJ Open Diabetes Res Care, 2020; 8, e000972. doi:  10.1136/bmjdrc-2019-000972
    [28] VanderWeele TJ. A unification of mediation and interaction: a 4-way decomposition. Epidemiology, 2014; 25, 749−61. doi:  10.1097/EDE.0000000000000121
    [29] Buscot MJ, Thomson RJ, Juonala M, et al. Distinct child-to-adult body mass index trajectories are associated with different levels of adult cardiometabolic risk. Eur Heart J, 2018; 39, 2263−70. doi:  10.1093/eurheartj/ehy161
    [30] Nano J, Dhana K, Asllanaj E, et al. Trajectories of BMI before diagnosis of type 2 diabetes: the Rotterdam study. Obesity, 2020; 28, 1149−56. doi:  10.1002/oby.22802
    [31] Viner RM, Costa S, Johnson W. Patterns of BMI development between 10 and 42 years of age and their determinants in the 1970 British Cohort Study. J Epidemiol Community Health, 2019; 73, 79−85. doi:  10.1136/jech-2018-211051
    [32] Kelly Y, Patalay P, Montgomery S, et al. BMI development and early adolescent psychosocial well-being: UK millennium cohort study. Pediatrics, 2016; 138, e20160967. doi:  10.1542/peds.2016-0967
    [33] Wang XJ, Dong B, Huang SZ, et al. Body mass index trajectory and incident hypertension: results from a longitudinal cohort of Chinese children and adolescents, 2006-2016. Am J Public Health, 2020; 110, 1689−95. doi:  10.2105/AJPH.2020.305873
    [34] Zhang T, Zhang HJ, Li Y, et al. Temporal relationship between childhood body mass index and insulin and its impact on adult hypertension: the Bogalusa heart study. Hypertension, 2016; 68, 818−23. doi:  10.1161/HYPERTENSIONAHA.116.07991
    [35] Wang TG, Lu JL, Shi LX, et al. Association of insulin resistance and β-cell dysfunction with incident diabetes among adults in China: a nationwide, population-based, prospective cohort study. Lancet Diabetes Endocrinol, 2020; 8, 115−24. doi:  10.1016/S2213-8587(19)30425-5
    [36] Lynch J, Smith GD. A life course approach to chronic disease epidemiology. Annu Rev Public Health, 2005; 26, 1−35. doi:  10.1146/annurev.publhealth.26.021304.144505
    [37] Ben-Shlomo Y, Kuh D. A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives. Int J Epidemiol, 2002; 31, 285−93. doi:  10.1093/ije/31.2.285
    [38] Hanson MA, Cooper C, Aihie Sayer A, et al. Developmental aspects of a life course approach to healthy ageing. J Physiol, 2016; 594, 2147−60. doi:  10.1113/JP270579
    [39] Wang FN, Deeney JT, Denis GV. Brd2 gene disruption causes "metabolically healthy" obesity: epigenetic and chromatin-based mechanisms that uncouple obesity from type 2 diabetes. Vitam Horm, 2013; 91, 49−75.
    [40] Navarro E, Funtikova AN, Fíto M, et al. Can metabolically healthy obesity be explained by diet, genetics, and inflammation? Mol Nutr Food Res, 2015; 59, 75-93.
    [41] Weiss R, Taksali SE, Dufour S, et al. The "obese insulin-sensitive" adolescent: importance of adiponectin and lipid partitioning. J Clin Endocrinol Metab, 2005; 90, 3731−7. doi:  10.1210/jc.2004-2305
    [42] Choi WJ, Jin HS, Kim SS, et al. Dietary protein and fat intake affects diabetes risk with CDKAL1 genetic variants in Korean adults. Int J Mol Sci, 2020; 21, 5607. doi:  10.3390/ijms21165607
    [43] Azevedo PS, Polegato BF, Paiva S, et al. The role of glucose metabolism and insulin resistance in cardiac remodelling induced by cigarette smoke exposure. J Cell Mol Med, 2021; 25, 1314−8. doi:  10.1111/jcmm.16053
    [44] Wu WC, Wei JN, Chen SC, et al. Progression of insulin resistance: a link between risk factors and the incidence of diabetes. Diabetes Res Clin Pract, 2020; 161, 108050. doi:  10.1016/j.diabres.2020.108050
    [45] Tanaka M, Itoh H. Hypertension as a metabolic disorder and the novel role of the gut. Curr Hypertens Rep, 2019; 21, 63. doi:  10.1007/s11906-019-0964-5
  • [1] Yang Liu, Bingjie Wu, Bingbing Fan, Chunxia Li, Chang Su, Aidong Liu, Tao Zhang.  Association between Solid Cooking Fuel Use and Frailty Trajectories: Findings from a Nationwide Cohort in China . Biomedical and Environmental Sciences, doi: 10.3967/bes2025.022
    [2] Monireh Faghir-Ganji, Narjes Abdolmohammadi, Maryam Nikbina, Alireza Amanollahi, Alireza Ansari-Moghaddam, Rozhan Khezri, Hamidreza Baradaran.  Prevalence of Anemia in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis . Biomedical and Environmental Sciences, doi: 10.3967/bes2024.008
    [3] LI Ya Mei, ZOU Zhi Yong, MA Ying Hua, LUO Jia You, JING Jin, ZHANG Xin, LUO Chun Yan, WANG Hong, ZHAO Hai Ping, PAN De Hong, LUO Mi Yang.  Predicting Metabolic Syndrome Using Anthropometric Indices among Chinese Adolescents with Different Nutritional Status: A Multicenter Cross-sectional Study . Biomedical and Environmental Sciences, doi: 10.3967/bes2021.095
    [4] XU Lu, YU Shu Qing, GAO Le, HUANG Yi, WU Shan Shan, YANG Jun, SUN Yi Xin, YANG Zhi Rong, CHAI San Bao, ZHANG Yuan, JI Li Nong, SUN Feng, ZHAN Si Yan.  Effects of Incretin-based Therapies on Weight-related Indicators among Patients with Type 2 Diabetes: A Network Meta-analysis . Biomedical and Environmental Sciences, doi: 10.3967/bes2020.005
    [5] MA Yan, HUANG Mai Ling, LI Tao, DU Jian, SHU Wei, XIE Shi Heng, WANG Hong Hong, ZHU Guo Feng, TAN Shou Yong, FU Yan Yong, MA Li Ping, ZHANG Lian Ying, LIU Fei Ying, HU Dai Yu, ZHANG Yan Ling, LI Xiang Qun, LIU Yu Hong, LI Liang.  Role of Diabetes Mellitus on Treatment Effects in Drug-susceptible Initial Pulmonary Tuberculosis Patients in China . Biomedical and Environmental Sciences, doi: 10.3967/bes2017.089
    [6] CHENG Jun, ZHANG Hui, ZHAO Yan Lin, WANG Li Xia, CHEN Ming Ting.  Mutual Impact of Diabetes Mellitus and Tuberculosis in China . Biomedical and Environmental Sciences, doi: 10.3967/bes2017.051
    [7] HE Huan, ZHEN Qing, LI Yong, KOU Chang Gui, TAO Yu Chun, WANG Chang, JosepHSam Kanu, LU Yu Ping, YU Ming Xi, ZHANG Hui Ping, YU Ya Qin, LI Bo, LIU Ya Wen.  Prevalence of High Non-high-density Lipoprotein Cholesterol and Associated Risk Factors in Patients with Diabetes Mellitus in Jilin Province, China:A Cross-sectional Study . Biomedical and Environmental Sciences, doi: 10.3967/bes2016.071
    [8] ZHAI Yi, LI Wei Rong, SHEN Chong, Frank QIAN, SHI Xiao Ming.  Prevalence and Correlates of Elevated Blood Pressure in Chinese Children Aged 6-13 Years:a Nationwide School-Based Survey . Biomedical and Environmental Sciences, doi: 10.3967/bes2015.057
    [9] YANG Fang, CHEN Xiang Ding, TAN Li Jun, SHEN Jie, LI Ding You, ZHANG Fang, SHA Bao Yong, DENG Hong Wen.  Genome Wide Association Study:Searching for Genes Underlying Body Mass Index in the Chinese . Biomedical and Environmental Sciences, doi: 10.3967/bes2014.061
    [10] WANG Jin Wei, TANG Xun, LI Na, WU Yi Qun, LI Shuai, LI Jin, QIN Xue Ying, ZHANG Zong Xin, HU Yong Hua, CHEN Da Fang.  The Impact of Lipid-metabolizing Genetic Polymorphisms on Body Mass Index and Their Interactions with Soybean Food Intake:A Study in a Chinese Population . Biomedical and Environmental Sciences, doi: 10.3967/bes2014.039
    [11] JI Cheng Ye, CHEN Tian Jiao, SUN Xiao.  Secular Changes on the Distribution of Body Mass Index among Chinese Children and Adolescents, 1985-2010 . Biomedical and Environmental Sciences, doi: 10.3967/0895-3988.2013.07.002
    [12] XI Bo, MI Jie.  Genome-wide Association Studies of Common Obesity: Now and Future . Biomedical and Environmental Sciences, doi: 10.3967/bes2013.001
    [13] Syed Shahid HABIB.  Body Mass Index and Body Fat Percentage in Assessment of Obesity Prevalence in Saudi Adults . Biomedical and Environmental Sciences, doi: 10.3967/0895-3988.2013.02.003
    [14] ZHONG Yuan, ZHANG Xiao Yan, MIAO Ya, ZHU Jie Hua, YAN Hong, WANG Bei Yun, JIN Jun, HU Ting Jun, JIA Wei Ping.  The Relationship between Glucose Excursion and Cognitive Function in Aged Type 2 Diabetes Patients . Biomedical and Environmental Sciences, doi: 10.3967/0895-3988.2012.01.001
    [15] MIN YANG, CHANG-CHUN QIU, QUN XU, HONG-DING XIANG.  Association of Angiotensin Converting Enzyme Gene I/D Polymorphism With Type 2 Diabetes Mellitus . Biomedical and Environmental Sciences,
    [16] WEI-LI YAN, YU-JIAN ZHENG, JUN WU, SHU-FENG CHEN, XIAO-KAI TI, LING LI, XIAO-RUI LIU.  Ethnic Differences in Body Mass Index and Prevalence of Obesity in School Children of Urumqi City, Xinjiang, China . Biomedical and Environmental Sciences,
    [17] JUN-FU ZHOU, JI-YUE WANG, YAN-ER LUO, Huai-Hong Chen.  Influence of Hypertension, Lipometabolism Disorders, Obesity and Other Lifestyles on Spontaneous Intracerebral Hemorrhage . Biomedical and Environmental Sciences,
    [18] XU HONG, TAN SHU_MEI, LI SHU_QING.  Effects of Soybean Fibers on Blood Sugar, Lipid Levels and Hepatic_Nephritic Histomorphology in Mice With Diabetes Mellitus . Biomedical and Environmental Sciences,
    [19] LI XIN-HUA, LI TIAN-LIN, YANG Ze, LIU ZUN-YONG, WEI YI-DA, JIN SHU-XIANG, CHEN HONG, QIN RU-LI, LI Yan-qing, JANICE S.DORMAN, RONALD E.LAPORTE, WANG KE-AN.  A Nine-Year Prospective Study on the Incidence of Childhood Type 1 Diabetes Mellitus in China . Biomedical and Environmental Sciences,
    [20] WANG ZENG-ZHEN, HUANG XU-ZHEN, TANG SI-BIN, CHEN YONG-MEI, CHEN LI-GONG, JIN ZHI-XIN, LUAN XIAO-JUN, ZHANG JIAN-HUA.  The Prevalence of NIDDM and IGT and Related Factors Among Residents in Some Areas of Hubei Province, China . Biomedical and Environmental Sciences,
  • 加载中
图(3) / 表ll (3)
计量
  • 文章访问数:  18
  • HTML全文浏览量:  7
  • PDF下载量:  2
  • 被引次数: 0
出版历程
  • 收稿日期:  2024-08-21
  • 录用日期:  2025-03-05

Life-Course Trajectories of Body Mass Index, Insulin Resistance, and Incident Diabetes in Chinese Adults

doi: 10.3967/bes2025.072
注释:
1) Authors' Contributions: 2) Competing Interests: 3) Ethics:

English Abstract

Zhiyuan Ning, Jinglan Zhang, Bingbing Fan, Yanlin Qu, Chang Su, Tao Zhang. Life-Course Trajectories of Body Mass Index, Insulin Resistance, and Incident Diabetes in Chinese Adults[J]. Biomedical and Environmental Sciences. doi: 10.3967/bes2025.072
Citation: Zhiyuan Ning, Jinglan Zhang, Bingbing Fan, Yanlin Qu, Chang Su, Tao Zhang. Life-Course Trajectories of Body Mass Index, Insulin Resistance, and Incident Diabetes in Chinese Adults[J]. Biomedical and Environmental Sciences. doi: 10.3967/bes2025.072
    • The prevalence of obesity has greatly increased in China[1-3], with approximately 46% of adults and 15% of children being obese or overweight, representing a severe public health challenge. Diabetes is one of the most common metabolic diseases worldwide, with an estimated prevalence of 12.4% in China in 2018 data[4]. The relationship between obesity and metabolic diseases has been well-established in observational studies[5-7]. However, the prevalence of metabolic diseases varies widely among the obese population[8]. Metabolically healthy obesity (MHO) populations are less likely to develop metabolic diseases than metabolically unhealthy obesity populations[9,10]. Preserved insulin sensitivity (IS) may modify the obesity-disease association[10-16]. Nevertheless, a few studies reported that insulin resistance (IR) mediates the relationship between obesity and diseases[17,18], leaving the interplay controversial, especially concerning diabetes.

      Generally, this interplay includes interaction and mediation effects[10-16]. The interaction effect suggests that IS may reduce the impact of obesity on diabetes, which is explained as metabolically healthy obesity[10-13]. The mediation effect supports the idea that obesity leads to IR and further causes diabetes, leaving metabolically healthy obesity a paradox[17,18]. Researchers evaluated the relationship between obesity and IR on incident diabetes[13-18]. However, these studies focused only on the interaction or mediation separately, ignoring the complex relationship between obesity and IR. Moreover, these studies were based on one or a limited number of measurements, ignoring the dynamic trends in body weight and metabolic status. Longitudinal studies that synthetically consider the interplay between obesity and IR on diabetes are largely limited, leaving the relationship uncertain[19-21].

      Using data from the China Health and Nutrition Survey (CHNS), this study aims to identify body mass index (BMI) trajectories during early to midlife adulthood (20–50 years) and illustrate the interplay between BMI trajectories and IR on incident diabetes.

    • The CHNS is an ongoing longitudinal cohort study conducted by the national and local governments[22]. This study aimed to understand how the social and economic transformation of Chinese society affects the health and nutritional status of the Chinese population. A multi-stage random clustering process was used to collect data from Beijing, Chongqing, Guangxi, Guizhou, Heilongjiang, Henan, Hubei, Hunan, Jiangsu, Liaoning, Shaanxi, Shandong, Shanghai, Yunnan, and Zhejiang. Ten cross-sectional surveys have been completed between 1989 and 2015, covering 41,462 individuals.

      In this study, individuals with a history of diabetes mellitus before 2009, BMI < 15 kg/m2 or BMI > 40 kg/m2, age > 50 or age < 20 until 2009, missing data in glucose or insulin in 2009, and with less than three follow-up visits until 2009 were excluded. Finally, 2,336 subjects (1,080 males, aged 20.0–44.8 years at baseline), with 3–10 times follow-ups, were included in this study. The mean follow-up duration was 18.2 years (SD = 6.0 years). BMI and diabetes mellitus data were collected between 1989 and 2009 and 2009 and 2015, respectively. Supplementary Figure S1 shows the detailed flowchart of the study population inclusion and exclusion. The Institutional Review Committee of the University of North Carolina in Chapel Hill, NC, USA, and the China National Institute of Nutrition and Food Safety at the Chinese Center for Disease Control and Prevention in Beijing, China, approved the study protocols. All the study participants provided written informed consent.

    • At each follow-up, standing height without shoes was measured to the nearest 0.2 cm using a portable SECA stadiometer (SECA, Hamburg, Germany). Weight in light clothing without shoes was measured to the nearest 0.1 kg on a dedicated scale that was routinely calibrated. BMI was calculated as weight in kilograms divided by height in meters squared (kg/m²). Smoking was defined as ever having smoked cigarettes (including former and current smokers). Alcohol drinking was defined as alcohol consumption (including beer, liquor, or wine) ≥ 25 g (for males) or ≥ 15 g (for females) per week. Waist circumference (WC) was measured midway between the lowest rib margin and the top of the iliac crest using a SECA tape measure from 1993 to 2015. Blood pressure was measured at least three times between 1991 and 2015 using a standard mercury sphygmomanometer after the participants rested for at least 5 minutes in a seated position. Systolic blood pressure (SBP) was measured at the first appearance of a pulse sound (Korotkoff phase 1), whereas diastolic blood pressure (DBP) was measured at the disappearance of the pulse sound (Korotkoff phase 5). The mean of the last two measurements was calculated for further analysis.

      The dietary assessment was based on a combination of detailed food consumption information for three consecutive days. Food consumption information was transformed into food groups based on the nutrient profiles designed for the 2002 China National Nutrition Survey[23].

      Biomarker data were collected from the 2009 CHNS survey. All adult participants were required to collect 12 mL of blood (in three 4 mL tubes) after overnight fasting. Serum glucose (using the glucose oxidase method) and whole glycated hemoglobin levels were measured using an automatic clinical chemistry analyzer (model HLC-723G7; Tosoh, Tokyo, Japan). Fasting serum insulin concentration was evaluated using a commercial radioimmunoassay kit (Beijing North Institute of Biological Technology, Beijing, China). IR status was assessed using the homeostasis model assessment of insulin resistance (HOMA-IR) according to the formula described previously: HOMA-IR = insulin (μU/mL) × glucose (mmol/L)/22.5[24].

    • Diabetes mellitus was defined as self-reporting diabetes and/or fasting plasma glucose (FPG) ≥ 7.0 mmol/L and/or glycated hemoglobin ≥ 6.5% (48 mmol/L) and/or taking glucose-lowering medication. Data on the incidence of self-reported diabetes and glucose-lowering medications were first collected in 1997 and subsequently in 2000, 2004, 2006, 2009, 2011, and 2015. Serum glucose and total glycated hemoglobin levels were measured only in the 2009 survey.

    • The latent class growth mixture model (LCGMM) was used to identify different trajectory patterns of BMI[25]. The latent class trajectory of BMI was specified as a function of age (centered to 35 years, the mean age of the cohort). Multiple LCGMMs with different trajectory shapes, including linear and nonlinear parameters, were tested[26,27]. Repeated trajectory analyses were performed to identify the latent classes by changing the number of groups from two to four with the same starting values calculated from the 1-group model. The class memberships of subjects were determined by a latent discrete random variable, and its probability was described using a multinomial logistic model according to the covariates. We chose the best-fitting model for the BMI trajectories according to the BIC criterion while ensuring that each group had an acceptable proportion of the population and posterior probability. Considering the changing patterns of BMI, subjects were divided into obese and normal-weight groups. The relationship between BMI trajectories and the level of HOMA-IR on incident diabetes was explored using a four-way effect decomposition model adjusted for baseline age, sex, smoking and alcohol consumption, and follow-up years[28]. Based on these results, we further estimated the detailed effects of BMI trajectories and HOMA-IR on incident diabetes.

      We defined IR as a HOMA-IR value above the 50th percentile. Combined with the BMI trajectories, the cohort was divided into four subgroups: normal, IR, IS-obesity, and IR-obesity. Logistic regression models were used to explore the associations between the joint group membership and incident diabetes mellitus adjusted for the same covariates. Moreover, the interaction effect between BMI trajectories and HOMA-IR was estimated by adding an interaction term in the logistic regression model. Mediation analysis models were constructed to examine whether the association between BMI trajectories and risk of diabetes was mediated by HOMA-IR, adjusted for the above covariates.

      Variables were described as mean (standard deviation), median (interquartile range), and n (%), as appropriate. All analyses were performed using R 4.0.4 and SAS 9.4. Statistical tests were two-sided, and P < 0.05 was considered statistically significant.

    • Table 1 presents the baseline characteristics of the study variables by the incident diabetes group during follow-up. Subjects with incident diabetes mellitus (n = 193) were more likely to be male and have higher BMI, FPG, insulin, and HOMA-IR values than non-diabetic subjects. Supplementary Table S1 shows that the excluded respondents (n = 39,126) were generally older subjects with lower baseline BMI, lower proportion of smokers, and higher FPG than those included.

      Table 1.  Characteristics by incident diabetes mellitus at baseline and follow-up

      Variables Non-diabetics (n = 2,142) Diabetes (n = 194) P Value
      Baseline
      Age, ys 28.0 (5.3) 28.4 (5.0) 0.344
      Males, n (%) 965 (45.1) 115 (59.3) < 0.001
      BMI, kg/m2 21.7 (2.7) 23.2 (3.4) < 0.001
      Smoker, n (%) 455 (21.2) 49 (25.3) 0.226
      Drinker, n (%) 473 (22.1) 50 (25.8) 0.275
      Follow-up
      FPG, mmol/L 5.0 (0.59) 7.2 (2.66) < 0.001
      Insulin, μIU/mL 10.2 [7.3, 14.5] 14.6 [9.2, 22.7] < 0.001
      HOMA 2.22 [1.54, 3.26] 4.47 [2.54, 8.39] < 0.001
      Follow-up duration, ys 18.0 (5.9) 20.6 (5.5) < 0.001
        Note. Study variables are presented as mean (SD), median [interquartile range] or n (%), appropriately. BMI, body mass index; FPG, fasting plasma glucose; HOMA, homeostasis model assessment of insulin resistance.
    • Supplementary Table S2 summarizes the LCGMM model-fitting process for BMI trajectories. We fit the models from one to four classes of linear, quadratic, and cubic curves. According to the statistical criteria above, a model of quadratic parameters with three classes was chosen as the best-fit model. Supplementary Table S3 presents the parameter estimates for the best-fitting 3-class quadratic latent class growth mixed model. All parameters were statistically significant (P < 0.05).

      Figure 1 shows the longitudinal trajectories of the BMI of 2,336 participants 20–50 years old. Three distinct trajectories were established: low-stable (n = 1,625, 69.56%), medium-increasing (n = 613, 26.24%), and high-increasing (n = 98, 4.20%). In the low-stable group, BMI persisted at a low level of 21–23 kg/m2, which was defined as normal weight. In the medium-increasing group, the BMI increased gradually from 21 kg/m2 to 26 kg/m2. In the high-increasing group, BMI increased gradually from 23 kg/m2 to 30 kg/m2. Individuals in the medium-increasing and high-increasing groups were defined as obese. Supplementary Table S4 presents the characteristics of the study variables by weight status. Compared to the normal-weight group, the obese group was more likely to be male, with higher baseline BMI, FPG, insulin, HOMA-IR, and a higher proportion of cigarette and alcohol consumption.

      Figure 1.  Predicted trajectories of BMI in participants 20–50 years old.

    • The relationship between BMI trajectories and HOMA-IR was explored using a four-way effect decomposition model. The reference interaction effect and pure indirect effect were 0.070 (P < 0.001) and 0.004 (P = 0.010), respectively. Both interaction and mediation effects between BMI trajectories and HOMA-IR were significant, and the interaction effect was primary.

      Subjects were divided into four subgroups based on the BMI trajectories and IR status: normal (low-stable BMI and IS, n = 948), IR (low-stable BMI and IR, n = 677), IS-obesity (medium- or high-increasing BMI and IS, n = 224), and IR-obesity (medium or high increasing BMI and IR, n = 487). Table 2 summarizes the baseline and follow-up characteristics of the study variables by the joint classes. Compared to the normal group, the IR-obesity group was more likely to be male, with a higher BMI, FPG, insulin, and HOMA-IR, and a higher proportion of smokers and alcohol drinkers at baseline and follow-up. Notably, compared to IS-obesity, subjects with IR obesity were more likely to be male, with the same BMI, SBP, DBP, WC, and smoking and alcohol drinking status at baseline, but significantly higher incremental WC, DBP, and proportion of cigarette consumption during follow-up. Furthermore, subjects in the IR-obesity group had more energy, fat, and protein intake but less carbohydrate intake during follow-up than those in the IS-obesity group.

      Table 2.  Characteristics at baseline and follow-up by joint groups of obesity and insulin sensitivity

      Variables Normal IR IS-obesity IR-obesity P Value
      N 948 677 224 487
      Baseline
      Age, ys 28.3 (5.2) 27.8 (5.2) 28.0 (5.5) 27.9 (5.3) 0.255
      Males, n (%) 409 (43.1) 290 (42.8) 104 (46.4) 277 (56.9) * † < 0.001
      BMI, kg/m2 20.8 (1.9) 21.0 (2.0) 24.0 (2.9) * 24.1 (3.1) * < 0.001
      SBP, mmHg 111.5 (11.6) 111.5 (11.6) 114.2 (11.2) * 115.8 (11.9) * < 0.001
      DBP, mmHg 73.4 (8.9) 73.0 (9.1) 75.8 (8.4) * 76.1 (9.3) * < 0.001
      WC, cm 72.9 (6.9) 73.9 (7.9) 82.3 (9.2) * 83.2 (9.7) * < 0.001
      Smoker, n (%) 199 (21.0) 113 (16.7) 53 (23.7) 139 (28.5) * < 0.001
      Drinker, n (%) 200 (21.1) 114 (16.8) 64 (28.6) * 145 (29.8) * < 0.001
      Follow-up (WAVE = 2009)
      Age, ys 41.9 (5.4) 41.5 (5.6) 40.9 (5.6) * 41.3 (5.6) * 0.031
      BMI, kg/m2 21.7 (2.2) 22.3 (2.2) 26.5 (2.3) * 27.5 (2.7) * † < 0.001
      SBP, mmHg 115.6 (13.7) 117.5 (14.4) 122.2 (16.4) * 124.3 (16.1) * < 0.001
      DBP, mmHg 76.8 (9.9) 77.8 (10.2) 81.4 (10.3) * 84.3 (11.5) * † < 0.001
      WC, cm 76.9 (8.0) 78.9 (7.8) 89.1 (7.8) * 91.1 (8.2) * † < 0.001
      Smoker, n (%) 293 (30.9) 182 (26.9) 66 (29.5) 182 (37.4) * † 0.002
      Drinker, n (%) 332 (35.1) 224 (33.1) 93 (41.5) 214 (43.9) * < 0.001
      Energy, kcal/day 2,242 (649) 2,133 (629) 2,252 (614) 2,293 (765) < 0.001
      Carbohydrate, g/day 313.1 (103.1) 295.4 (102.1) 317.8 (98.0) 308.9 (107.0) 0.003
      Protein, g/day 68.2 (22.8) 66.7 (22.2) 69.3 (23.6) 71.4 (24.0) 0.007
      Fat intake, g/day 76.2 (33.6) 72.6 (32.5) 76.2 (30.9) 79.1 (34.9) 0.011
      FPG, mmol/L 4.8 (0.54) 5.4 (1.09) 4.9 (0.70) 5.8 (1.73) * † < 0.001
      Insulin, μIU/mL 7.3 [5.5, 8.7] 14.4 [11.9, 20.3] 7.9 [5.8, 9.0] * 16.1 [12.8, 22.8] * † < 0.001
      HOMA 1.55 [1.15, 1.92] 3.26 [2.71, 4.74] 1.71 [1.23, 1.96] * 3.83 [2.95, 5.85] * † < 0.001
      Incident Diabetes Mellitus, n (%) 29 (3.1) 60 (8.9) 13 (5.8) 92 (18.9) * † < 0.001
        Note. Study variables are presented as mean (SD), median [interquartile range] or n (%), appropriately. IR, insulin resistance; IS, insulin sensitivity; BMI, body mass index; DBP, diastolic blood pressure; SBP, systolic blood pressure; WC, waist circumference; FPG, fasting plasma glucose; HOMA, homeostasis model assessment of insulin resistance. * Indicated P < 0.05 adjusted for Bonferroni, compared with normal group. Indicated P < 0.05 adjusted for Bonferroni, compared with IS-obesity group.
    • The incidence estimates of diabetes across different combined categories of BMI trajectories and insulin resistance status are presented in Figure 2. The proportion of incident diabetes was higher in the IR-obesity than in the IS-obesity group (18.9% vs. 5.8%, P < 0.001), and an interaction effect on incident diabetes was found between BMI trajectories and HOMA-IR (β = 0.76, P < 0.001). These results were consistent in males and females.

      Figure 2.  Incidence of diabetes in participants 20–50 years old across different combined categories of BMI and HOMA-IR.

      Table 3 presents the odds ratios (ORs) and 95% confidence intervals (CIs) for the association between joint group membership and incident diabetes mellitus. Compared with the normal group, the ORs (95% CIs) of IR, IS-obesity, and IR-obesity groups were 3.08 (1.97, 4.92), 1.95 (0.97, 3.74), and 7.38 (4.84, 11.57) in the unadjusted model, respectively. After adjusting for baseline age, sex, smoking, alcohol consumption status, and follow-up years, the ORs (95% CIs) were 3.22 (2.05, 5.16), 2.05 (1.00, 3.97), and 7.98 (5.19, 12.62), respectively. People in the IR-obesity group had a four-fold higher risk of developing incident diabetes mellitus than those in the IS-obesity group (P < 0.001). These results were consistent in males and females.

      Table 3.  Odds ratios (95% CI) of joint groups of obesity and insulin sensitivity for incident diabetes

      Model 1* Model 2** Model 3***
      Total
      Normal Reference Reference Reference
      IR 3.08 (1.97, 4.92) 3.13 (2.00, 5.00) 3.22 (2.05, 5.16)
      IS-obesity 1.95 (0.97, 3.74) 1.94 (0.96, 3.72) 2.05 (1.00, 3.97)
      IR-obesity 7.38 (4.84, 11.57) 7.05 (4.62, 11.07) 7.98 (5.19, 12.62)
      Males
      Normal Reference Reference Reference
      IR 2.96 (1.64, 5.54) 3.01 (1.66, 5.64) 3.05 (1.67, 5.74)
      IS-obesity 1.66 (0.63, 3.97) 1.68 (0.64, 4.03) 1.86 (0.69, 4.53)
      IR-obesity 6.11 (3.54, 11.05) 6.17 (3.58, 11.17) 7.32 (4.20, 13.41)
      Females
      Normal Reference Reference Reference
      IR 3.29 (1.68, 6.83) 3.30 (1.69, 6.84) 3.40 (1.73, 7.09)
      IS-obesity 2.31 (0.79, 6.08) 2.31 (0.79, 6.09) 2.25 (0.76, 6.02)
      IR-obesity 8.48 (4.42, 17.41) 8.50 (4.42, 17.44) 8.65 (4.45, 17.93)
        Note. IR, insulin resistance; IS, insulin sensitivity. * Unadjusted for any covariates. ** Adjusted for baseline age and sex (only for total). *** Adjusted for baseline age, sex (only for total), smoking, alcohol drinking, and follow-up years. Indicated P value < 0.05.
    • Figure 3 shows the mediation effect of HOMA-IR on the association between BMI trajectories and diabetes in midlife. After adjusting for sex, baseline age, smoking, alcohol consumption, and follow-up years, the total effect of the obesity group on diabetes mellitus (measured as standardized regression coefficients) was 0.093 (P < 0.001). The indirect effect of obesity on HOMA-IR (β1) and HOMA-IR on diabetes (β2) was 0.238 (P < 0.001) and 0.042 (P < 0.001), respectively. The overall indirect effect (β1 × β2) was 0.010 (P < 0.001). The percentage of the total effect mediated by the HOMA-IR was 10.7% (P < 0.001).

      Figure 3.  Mediation effect of HOMA-IR on the BMI trajectories to later life diabetes mellitus association.

    • In this longitudinal study of the Chinese population, we identified three distinct BMI trajectories from ages 20 to 50 and found both interaction and mediation effects between BMI trajectories and HOMA-IR on incident diabetes. Accumulated obesity in early to midlife is associated with incident diabetes, with modification and mediation effects of IR. Notably, obese individuals with IS aged 20–50 years presented a four-fold lower risk of diabetes than those with IR, indicating that IS obesity may be a distinct metabolically healthy subgroup. A larger number of normal-weight subjects with IR presented a higher risk of incident diabetes than the normal-weight group. Therefore, more attention should be paid to metabolic disorders in the obese population to prevent diabetes mellitus.

      In the current study, we identified three distinct BMI trajectories in participants between 20 and 50 years of age. In the low-stable group, the BMI persisted at a low level of 21–23 kg/m2. In the medium-increasing group, BMI increased to 24 kg/m2 at approximately 30 years of age. In the high-increasing group, BMI increased from 24 kg/m2 to 30 kg/m2. Wei et al. defined obesity as a BMI > 24 kg/m2 at baseline in China[14]. In our study, participants in both the medium-increasing and high-increasing groups had a BMI > 24 kg/m2 in early adulthood, which is defined as obesity from a life-course perspective. Previous studies using data from China, Britain, and Finland identified 2–6 distinct BMI trajectories in adulthood[26,27,29-33]. Although the number of trajectories differed among these studies, they all discovered a low-stable group and a high-increasing group[26,27,29-33].

      The role of IR in the BMI-diabetes association is unclear. In this longitudinal study, using four-way effect decomposition, we found that both interaction and mediation effects were significant and that the interaction effect was primary. The relationship between BMI and insulin levels in chronic diseases remains controversial. Zhang et al.[34] reported that the BMI-hypertension association is mediated by insulin (proportion of mediation effect = 21.1%) Wang et al.[35] presented an interaction effect between obesity and IR in diabetes research (HR = 2.02, P = 0.009). However, previous studies mainly focused on the mediation or interaction effect separately[10,17,18,34,35]. To the best of our knowledge, studies using a four-way decomposition to explore the interplay between BMI and IR on diabetes are still largely limited. Our results suggested that the interplay between BMI trajectories and HOMA-IR on incident diabetes is complicated and underscored that both BMI and IR should be controlled in early adulthood to prevent diabetes.

      Notably, the interaction between obesity and IR is usually explained by MHO[13,16]. Some studies demonstrated that preserved IS is common in metabolically healthy obese individuals[10-12]. Previous studies[13-16] used baseline data to define MHO, ignoring the dynamic trends[10,13-16]. Obese individuals with a transition from metabolic health to metabolic disorders may be ignored. In the current study, we defined obesity using the BMI trajectories from 20 to 50 years, and metabolic health as IS (HOMA-IR value above the 50th percentile), which was similar to the findings of Zhang et al.[10]. Using longitudinal BMI profiles, subjects who transitioned from normal weight to obese (medium-increasing group) were correctly identified. Furthermore, the transition of metabolic status could be addressed using the final HOMA-IR data in the cohort to define IS. Only individuals with obesity for at least 5 years (from the 2004 to 2009 survey) and metabolic health were defined as MHO.

      Moreover, it remains controversial whether MHO individuals are a really healthy subgroup[13-15]. Our results showed that the IR-obesity group had a higher risk of incident diabetes mellitus (OR = 7.98, 95% CI = 5.19–12.62) than the normal group, while the IS-obesity group did not seem to have a higher risk (OR = 2.05, 95% CI = 1.00–3.97). A four-fold higher risk was found in the IR-obesity group than in the IS-obesity group. This is in line with previous studies[10,13,16] indicating that obese and metabolically healthy populations should receive more attention in terms of diabetes[10]. Wei et al.[14]reported that metabolically healthy obesity increases the incidence of diabetes in the middle-aged and elderly Chinese population. However, the study may overestimate the risk of diabetes in MHO subjects because they defined the metabolically healthy obesity group using only baseline data, ignoring the changing patterns[14]. Furthermore, the IR group had a higher risk of diabetes, indicating that more attention should be paid to metabolic health in the obese population to prevent diabetes.

      According to the life-course epidemiology theory, exposure at a specific period and its cumulative effect during the lifespan can greatly affect the development of diseases in later life.36-38 Our results showed that MHO individuals had a lower risk of developing diabetes. This may be caused by changes during early adulthood, such as bromodomain-containing protein 2 (brd2) gene disruption, diet, and inflammation[39-42]. Brd2 is associated with the transcriptional regulatORs of obesity and diabetes[39]. Obesity and IR are both influenced by lifestyle and diet[40]. High dietary fat intake may cause IR and result in a higher incidence of diabetes[41], while protein intake may reduce insulin resistance[41]. Compared to obese individuals with IS, those with IR might have additional predisposing fact ORs, such as higher lipid deposition in the intramyocellular and visceral compartments and lower adiponectin levels[42]. Moreover, in this longitudinal study, IR-obesity subjects were more likely to be smokers, with higher incremental WC and DBP than IS-obese subjects during follow-up. Previous studies demonstrated that smoking, incremental WC, and blood pressure are associated with IR[43-45]. Under these conditions, adjusting dietary patterns, controlling WC and blood pressure, and cessation of smoking may reduce the risk of IR and diabetes mellitus.

      This study had several strengths. First, this was a community-based longitudinal study with a large sample size and repeated measurements. This allowed us to explore the BMI trajectories. Second, we defined metabolically healthy obesity using BMI trajectories and final IS status in this cohort, considering the transformation of body weight and metabolic status. Furthermore, we tested the associations between the joint groups and later diabetes, proving that obese subjects with metabolic health do not seem to have a higher risk of incident diabetes mellitus, which is more convincing than the findings of previous studies. Moreover, using the four-way effect decomposition method, we found that both interaction and mediation effects exist between BMI trajectories and HOMA-IR in diabetes research. However, this study has some limitations. First, the outcome assessments relied on self-reported data with only one biomarker collected in 2009, leading to a higher incidence of diabetes in the 2009 survey than in the other surveys. The incidence of diabetes was underestimated in the CHNS, which may have biased the logistic model results. Second, although we adjusted for covariates in our models, unobserved confounders, such as genetic background, family history, comorbidities, socioeconomic status, and additional metabolic conditions, might still influence the results. Third, the HOMA-IR was collected only in 2009 in the CHNS, leaving its dynamic changing patterns unclear. Further studies should identify the trajectory of HOMA-IR to illustrate the metabolically healthy obesity theory more strongly. Finally, the CHNS is concentrated in the Chinese population. Therefore, our results may not be generalizable to other ethnic populations.

    • In conclusion, the interplay between BMI trajectories and IR on incident diabetes mellitus was mainly an interaction effect, and the insulin-sensitive obesity group was relatively healthy compared to the insulin-resistant obesity group regarding incident diabetes. Our findings provide evidence that a metabolically healthy obesity phenotype protects against the risk of diabetes. Targeted strategies for diabetes prevention should be emphasized in normal, insulin-resistant, insulin-sensitive, and insulin-resistant obese individuals. Public health interventions to control both BMI and IR in young adults are important for preventing diabetes mellitus.

参考文献 (45)

目录

    /

    返回文章
    返回